BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 32149126)

  • 1. S100A9 Increases IL-6 and RANKL Expressions through MAPKs and STAT3 Signaling Pathways in Osteocyte-Like Cells.
    Takagi R; Sakamoto E; Kido JI; Inagaki Y; Hiroshima Y; Naruishi K; Yumoto H
    Biomed Res Int; 2020; 2020():7149408. PubMed ID: 32149126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S100A9-induced release of interleukin (IL)-6 and IL-8 through toll-like receptor 4 (TLR4) in human periodontal ligament cells.
    Gao H; Zhang X; Zheng Y; Peng L; Hou J; Meng H
    Mol Immunol; 2015 Oct; 67(2 Pt B):223-32. PubMed ID: 26038301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proinflammatory effects and mechanisms of calprotectin on human gingival fibroblasts.
    Gao H; Hou J; Meng H; Zhang X; Zheng Y; Peng L
    J Periodontal Res; 2017 Dec; 52(6):975-983. PubMed ID: 28643937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced glycation end products increase expression of S100A8 and A9 via RAGE-MAPK in rat dental pulp cells.
    Nakajima Y; Inagaki Y; Kido J; Nagata T
    Oral Dis; 2015 Apr; 21(3):328-34. PubMed ID: 25098709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calprotectin Induces IL-6 and MCP-1 Production via Toll-Like Receptor 4 Signaling in Human Gingival Fibroblasts.
    Nishikawa Y; Kajiura Y; Lew JH; Kido JI; Nagata T; Naruishi K
    J Cell Physiol; 2017 Jul; 232(7):1862-1871. PubMed ID: 27925202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TLR4 and RAGE conversely mediate pro-inflammatory S100A8/9-mediated inhibition of proliferation-linked signaling in myeloproliferative neoplasms.
    Kovačić M; Mitrović-Ajtić O; Beleslin-Čokić B; Djikić D; Subotički T; Diklić M; Leković D; Gotić M; Mossuz P; Čokić VP
    Cell Oncol (Dordr); 2018 Oct; 41(5):541-553. PubMed ID: 29946821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretion of the Phosphorylated Form of S100A9 from Neutrophils Is Essential for the Proinflammatory Functions of Extracellular S100A8/A9.
    Schenten V; Plançon S; Jung N; Hann J; Bueb JL; Bréchard S; Tschirhart EJ; Tolle F
    Front Immunol; 2018; 9():447. PubMed ID: 29593718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proinflammatory effects of S100A8/A9 via TLR4 and RAGE signaling pathways in BV-2 microglial cells.
    Ma L; Sun P; Zhang JC; Zhang Q; Yao SL
    Int J Mol Med; 2017 Jul; 40(1):31-38. PubMed ID: 28498464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-6 Enhances Osteocyte-Mediated Osteoclastogenesis by Promoting JAK2 and RANKL Activity In Vitro.
    Wu Q; Zhou X; Huang D; Ji Y; Kang F
    Cell Physiol Biochem; 2017; 41(4):1360-1369. PubMed ID: 28278513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alarmins S100A8 and S100A9 elicit a catabolic effect in human osteoarthritic chondrocytes that is dependent on Toll-like receptor 4.
    Schelbergen RF; Blom AB; van den Bosch MH; Slöetjes A; Abdollahi-Roodsaz S; Schreurs BW; Mort JS; Vogl T; Roth J; van den Berg WB; van Lent PL
    Arthritis Rheum; 2012 May; 64(5):1477-87. PubMed ID: 22127564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced glycation end-products and Porphyromonas gingivalis lipopolysaccharide increase calprotectin expression in human gingival epithelial cells.
    Hiroshima Y; Sakamoto E; Yoshida K; Abe K; Naruishi K; Yamamoto T; Shinohara Y; Kido JI; Geczy CL
    J Cell Biochem; 2018 Feb; 119(2):1591-1603. PubMed ID: 28771806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipopolysaccharide increases IL-6 secretion via activation of the ERK1/2 signaling pathway to up-regulate RANKL gene expression in MLO-Y4 cells.
    Yu K; Ma Y; Li X; Wu X; Liu W; Li X; Shen J; Wang H
    Cell Biol Int; 2017 Jan; 41(1):84-92. PubMed ID: 27778412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD68 on rat macrophages binds tightly to S100A8 and S100A9 and helps to regulate the cells' immune functions.
    Okada K; Arai S; Itoh H; Adachi S; Hayashida M; Nakase H; Ikemoto M
    J Leukoc Biol; 2016 Nov; 100(5):1093-1104. PubMed ID: 27312849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S100A8/9 modulates perturbation and glycolysis of macrophages in allergic asthma mice.
    Ji X; Nie C; Yao Y; Ma Y; Huang H; Hao C
    PeerJ; 2024; 12():e17106. PubMed ID: 38646478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alarmins S100A8/A9 promote intervertebral disc degeneration and inflammation-related pain in a rat model through toll-like receptor-4 and activation of the NF-κB signaling pathway.
    Zheng J; Wang J; Liu H; Chen F; Wang H; Chen S; Xie J; Zheng Z; Li Z
    Osteoarthritis Cartilage; 2022 Jul; 30(7):998-1011. PubMed ID: 35405347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced glycation end-product 2 and Porphyromonas gingivalis lipopolysaccharide increase sclerostin expression in mouse osteocyte-like cells.
    Sakamoto E; Kido JI; Takagi R; Inagaki Y; Naruishi K; Nagata T; Yumoto H
    Bone; 2019 May; 122():22-30. PubMed ID: 30735798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine secreted by S100A9 via TLR4 in monocytes delays neutrophil apoptosis by inhibition of caspase 9/3 pathway.
    Lee NR; Park BS; Kim SY; Gu A; Kim DH; Lee JS; Kim IS
    Cytokine; 2016 Oct; 86():53-63. PubMed ID: 27459393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RAGE-dependent regulation of calcium-binding proteins S100A8 and S100A9 in human THP-1.
    Eggers K; Sikora K; Lorenz M; Taubert T; Moobed M; Baumann G; Stangl K; Stangl V
    Exp Clin Endocrinol Diabetes; 2011 Jun; 119(6):353-7. PubMed ID: 21472666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S100A9 induces differentiation of acute myeloid leukemia cells through TLR4.
    Laouedj M; Tardif MR; Gil L; Raquil MA; Lachhab A; Pelletier M; Tessier PA; Barabé F
    Blood; 2017 Apr; 129(14):1980-1990. PubMed ID: 28137827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced glycation end products induced IL-6 and VEGF-A production and apoptosis in osteocyte-like MLO-Y4 cells by activating RAGE and ERK1/2, P38 and STAT3 signalling pathways.
    Chen H; Liu W; Wu X; Gou M; Shen J; Wang H
    Int Immunopharmacol; 2017 Nov; 52():143-149. PubMed ID: 28910744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.